<table class="drug-table data-table table table-condensed table-bordered"><tbody><tr id="identification"><th class="divider" colspan="2">Identification</th></tr><tr><th>Name</th><td><strong>Nicotine</strong></td></tr><tr><th>Accession Number</th><td><strong>DB00184</strong>&#160; (APRD00200, EXPT02315)</td></tr><tr><th>Type</th><td>small molecule</td></tr><tr><th>Groups</th><td>approved</td></tr><tr><th>Description</th><td><p>Nicotine is highly toxic alkaloid. It is the prototypical agonist at nicotinic cholinergic receptors where it dramatically stimulates neurons and ultimately blocks synaptic transmission. Nicotine is also important medically because of its presence in tobacco smoke. [PubChem]</p></td></tr><tr><th>Structure</th><td><div class="structure"><a class="moldbi-thumbnail" href="http://structures.wishartlab.com/molecules/DB00184/image.png"><img alt="Thumb" src="http://structures.wishartlab.com/molecules/DB00184/thumb.png"></a></div><div class="structure-links"><div class="btn-group btn-group-xs"><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB00184.mol">MOL</a><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB00184.sdf">SDF</a><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB00184.pdb">PDB</a><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB00184.smiles">SMILES</a><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB00184.inchi">InChI</a><a class="btn btn-info" href="/structures/structures/small_molecule_drugs/DB00184">View Structure</a></div></div></td></tr><tr><th>Synonyms</th><td class="data-table-container"><table class="table table-condensed table-striped datatable" id="synonyms"><thead><th>Synonym</th><th>Language</th><th>Code</th></thead><tbody><tr><td>(&#177;)-nicotine</td><td><span class="wishart wishart-not-available">Not Available</span></td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>(R,S)-nicotine</td><td><span class="wishart wishart-not-available">Not Available</span></td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>(RS)-nicotine</td><td><span class="wishart wishart-not-available">Not Available</span></td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>Nicotin</td><td><span class="wishart wishart-not-available">Not Available</span></td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>Nikotin</td><td><span class="wishart wishart-not-available">Not Available</span></td><td><span class="wishart wishart-not-available">Not Available</span></td></tr></tbody></table></td></tr><tr><th>Salts</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Brand names</th><td class="data-table-container"><table class="table table-condensed table-striped datatable" id="brands"><thead><tr><th>Name</th><th>Company</th></tr></thead><tbody><tr><td>Habitrol</td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>Nicoderm</td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>Nicoderm CQ</td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>Nicorette</td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>Nicotrol</td><td><span class="wishart wishart-not-available">Not Available</span></td></tr></tbody></table></td></tr><tr><th>Brand mixtures</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Categories</th><td><ul><li><a href="/mesh/ganglionic-stimulants">Ganglionic Stimulants</a></li>
<li><a href="/mesh/nicotinic-agonists">Nicotinic Agonists</a></li>
<li><a href="/mesh/appetite-depressants">Appetite Depressants</a></li>
<li><a href="/mesh/autonomic-agents">Autonomic Agents</a></li></ul></td></tr><tr><th>CAS number</th><td>54-11-5</td></tr><tr><th>Weight</th><td>Average: 162.2316<br>Monoisotopic: 162.115698458</td></tr><tr><th>Chemical Formula</th><td>C<sub>10</sub>H<sub>14</sub>N<sub>2</sub></td></tr><tr><th>InChI Key</th><td>SNICXCGAKADSCV-UHFFFAOYSA-N</td></tr><tr><th>InChI</th><td><div class="wrap">InChI=1S/C10H14N2/c1-12-7-3-5-10(12)9-4-2-6-11-8-9/h2,4,6,8,10H,3,5,7H2,1H3</div></td></tr><tr><th>IUPAC Name</th><td><div class="wrap">3-(1-methylpyrrolidin-2-yl)pyridine</div></td></tr><tr><th>SMILES</th><td><div class="wrap">CN1CCCC1C1=CN=CC=C1</div></td></tr><tr><th>Mass Spec</th><td><a href="/system/mass_specs/DB00184.gif?1265922772">show</a>(2.96 KB)</td></tr><tr id="taxonomy"><th class="divider" colspan="2">Taxonomy</th></tr><tr><th>Kingdom</th><td>Organic Compounds</td></tr><tr><th>Superclass</th><td>Alkaloids and Derivatives</td></tr><tr><th>Class</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Subclass</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Direct parent</th><td>Alkaloids and Derivatives</td></tr><tr><th>Alternative parents</th><td>Pyrrolidinylpyridines; Pyrrolidines; Tertiary Amines; Polyamines</td></tr><tr><th>Substituents</th><td>pyridine; pyrrolidine; tertiary amine; polyamine; amine; organonitrogen compound</td></tr><tr><th>Classification description</th><td>This compound belongs to the alkaloids and derivatives. These are naturally occurring chemical compounds that contain mostly basic nitrogen atoms. This group also includes some related compounds with neutral and even weakly acidic properties. Also some synthetic compounds of similar structure are attributed to alkaloids. In addition to carbon, hydrogen and nitrogen, alkaloids may also contain oxygen, sulfur and more rarely other elements such as chlorine, bromine, and phosphorus.</td></tr><tr id="pharmacology"><th class="divider" colspan="2">Pharmacology</th></tr><tr><th>Indication</th><td>For the relief of nicotine withdrawal symptoms and as an aid to smoking cessation.</td></tr><tr><th>Pharmacodynamics</th><td>Nicotine, the primary alkaloid in tobacco products binds stereo-selectively to nicotinic-cholinergic receptors on autonomic ganglia, the adrenal medulla, neuromuscular junctions and in the brain. Nicotine exerts two effects, a stimulant effect exerted at the locus ceruleus and a reward effect in the limbic system. Itranvenous administration of nicotine causes release of acetylcholine, norepinephrine, dopamine, serotonine, vasopressin, beta-endorphin and ACTH. Nicotine is a highly addictive substance. Nicotine also induces peripheral vasoconstriction, tachycardia and elevated blood pressure. Nicotine inhalers and patches are used to treat smoking withdrawl syndrome. Nicotine is classified as a stimulant of autonomic ganglia.</td></tr><tr><th>Mechanism of action</th><td>Nicotine is a stimulant drug that acts as an agonist at nicotinic acetylcholine receptors. These are ionotropic receptors composed up of five homomeric or heteromeric subunits. In the brain, nicotine binds to nicotinic acetylcholine receptors on dopaminergic neurons in the cortico-limbic pathways. This causes the channel to open and allow conductance of multiple cations including sodium, calcium, and potassium. This leads to depolarization, which activates voltage-gated calcium channels and allows more calcium to enter the axon terminal. Calcium stimulates vesicle trafficking towards the plasma membrane and the release of dopamine into the synapse. Dopamine binding to its receptors is responsible the euphoric and addictive properties of nicotine.
Nicotine also binds to nicotinic acetylcholine receptors on the chromaffin cells in the adrenal medulla. Binding opens the ion channel allowing influx of sodium, causing depolarization of the cell, which activates voltage-gated calcium channels. Calcium triggers the release of epinephrine from intracellular vesicles into the bloodstream, which causes vasoconstriction, increased blood pressure, increased heart rate, and increased blood sugar.</td></tr><tr><th>Absorption</th><td>Absorption of nicotine through the buccal mucosa is relatively slow and the high and rapid rise followed by the decline in nicotine arterial plasma concentrations seen with cigarette smoking are not achieved with the inhaler. About 10% of absorbed nicotine is excreted unchanged in urine.</td></tr><tr><th>Volume of distribution</th><td><ul>
	<li>2 to 3 L/kg</li>
</ul></td></tr><tr><th>Protein binding</th><td>Less than 5%</td></tr><tr><th>Metabolism</th><td class="data-table-container"><p>Primarily hepatic, cotinine is the primary metabolite.</p><table class="table-standard table-condensed" id="experimental-properties"><thead><tr><th>Substrate</th><th>Enzymes</th><th colspan="2">Product</th></tr></thead><tbody><tr><td>Nicotine</td><td class="enzymes"><div class="arrow"><span class="glyphicon glyphicon-arrow-right"> </span></div><span class="wishart wishart-not-available">Not Available</span></td><td><a href="/metabolites/DBMET00515">N-Methylnicotinium</a></td><td class="actions"><a class="btn btn-info btn-sm" href="/reactions/530">Details</a></td></tr><tr><td>Nicotine</td><td class="enzymes"><div class="arrow"><span class="glyphicon glyphicon-arrow-right"> </span></div><ul><li><a href="/biodb/bio_entities/BE0003336" target="_blank">Cytochrome P450 2A6</a></li>
<li><a href="/biodb/bio_entities/BE0003549" target="_blank">Cytochrome P450 2B6</a></li></ul></td><td><a href="/metabolites/DBMET00516">Nicotine imine</a></td><td class="actions"><a class="btn btn-info btn-sm" href="/reactions/531">Details</a></td></tr><tr><td>Nicotine</td><td class="enzymes"><div class="arrow"><span class="glyphicon glyphicon-arrow-right"> </span></div><span class="wishart wishart-not-available">Not Available</span></td><td><a href="/metabolites/DBMET00519">Cotinine</a></td><td class="actions"><a class="btn btn-info btn-sm" href="/reactions/534">Details</a></td></tr><tr><td>Nicotine</td><td class="enzymes"><div class="arrow"><span class="glyphicon glyphicon-arrow-right"> </span></div><span class="wishart wishart-not-available">Not Available</span></td><td><a href="/metabolites/DBMET00520">Nornicotine</a></td><td class="actions"><a class="btn btn-info btn-sm" href="/reactions/535">Details</a></td></tr><tr><td>Nicotine</td><td class="enzymes"><div class="arrow"><span class="glyphicon glyphicon-arrow-right"> </span></div><ul><li><a href="/biodb/bio_entities/BE0003544" target="_blank">UDP-glucuronosyltransferase 1-4</a></li>
<li><a href="/biodb/bio_entities/BE0003538" target="_blank">UDP-glucuronosyltransferase 1-9</a></li></ul></td><td><a href="/metabolites/DBMET00524">Nicotine glucuronide</a></td><td class="actions"><a class="btn btn-info btn-sm" href="/reactions/539">Details</a></td></tr><tr><td>Nicotine</td><td class="enzymes"><div class="arrow"><span class="glyphicon glyphicon-arrow-right"> </span></div><span class="wishart wishart-not-available">Not Available</span></td><td><a href="/metabolites/DBMET00526">Norcotinine</a></td><td class="actions"><a class="btn btn-info btn-sm" href="/reactions/541">Details</a></td></tr><tr><td>Nicotine</td><td class="enzymes"><div class="arrow"><span class="glyphicon glyphicon-arrow-right"> </span></div><ul><li><a href="/biodb/bio_entities/BE0003606" target="_blank">Dimethylaniline monooxygenase [N-oxide-forming] 3</a></li></ul></td><td><a href="/metabolites/DBMET00533">Nicotine-1'-N-oxide</a></td><td class="actions"><a class="btn btn-info btn-sm" href="/reactions/548">Details</a></td></tr><tr><td>Nicotine</td><td class="enzymes"><div class="arrow"><span class="glyphicon glyphicon-arrow-right"> </span></div><span class="wishart wishart-not-available">Not Available</span></td><td><a href="/metabolites/DBMET00613">4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone</a></td><td class="actions"><a class="btn btn-info btn-sm" href="/reactions/632">Details</a></td></tr><tr><td>Nicotine</td><td class="enzymes"><div class="arrow"><span class="glyphicon glyphicon-arrow-right"> </span></div><span class="wishart wishart-not-available">Not Available</span></td><td><a href="/metabolites/DBMET00643">4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanol</a></td><td class="actions"><a class="btn btn-info btn-sm" href="/reactions/664">Details</a></td></tr><tr><td><a href="/metabolites/DBMET00516">Nicotine imine</a></td><td class="enzymes"><div class="arrow"><span class="glyphicon glyphicon-arrow-right"> </span></div><ul><li><a href="/biodb/bio_entities/BE0003539" target="_blank">Aldehyde oxidase</a></li></ul></td><td><a href="/metabolites/DBMET00519">Cotinine</a></td><td class="actions"><a class="btn btn-info btn-sm" href="/reactions/1083">Details</a></td></tr><tr><td><a href="/metabolites/DBMET00519">Cotinine</a></td><td class="enzymes"><div class="arrow"><span class="glyphicon glyphicon-arrow-right"> </span></div><span class="wishart wishart-not-available">Not Available</span></td><td><a href="/metabolites/DBMET00529">Cotinine N-oxide</a></td><td class="actions"><a class="btn btn-info btn-sm" href="/reactions/1084">Details</a></td></tr><tr><td><a href="/metabolites/DBMET00519">Cotinine</a></td><td class="enzymes"><div class="arrow"><span class="glyphicon glyphicon-arrow-right"> </span></div><ul><li><a href="/biodb/bio_entities/BE0003336" target="_blank">Cytochrome P450 2A6</a></li></ul></td><td><a href="/metabolites/DBMET00527">3'-Hydroxycotinine</a></td><td class="actions"><a class="btn btn-info btn-sm" href="/reactions/1085">Details</a></td></tr><tr><td><a href="/metabolites/DBMET00519">Cotinine</a></td><td class="enzymes"><div class="arrow"><span class="glyphicon glyphicon-arrow-right"> </span></div><span class="wishart wishart-not-available">Not Available</span></td><td><a href="/metabolites/DBMET00520">Nornicotine</a></td><td class="actions"><a class="btn btn-info btn-sm" href="/reactions/1087">Details</a></td></tr><tr><td><a href="/metabolites/DBMET00519">Cotinine</a></td><td class="enzymes"><div class="arrow"><span class="glyphicon glyphicon-arrow-right"> </span></div><ul><li><a href="/biodb/bio_entities/BE0003606" target="_blank">Dimethylaniline monooxygenase [N-oxide-forming] 3</a></li></ul></td><td><a href="/metabolites/DBMET00533">Nicotine-1'-N-oxide</a></td><td class="actions"><a class="btn btn-info btn-sm" href="/reactions/1089">Details</a></td></tr><tr><td><a href="/metabolites/DBMET00519">Cotinine</a></td><td class="enzymes"><div class="arrow"><span class="glyphicon glyphicon-arrow-right"> </span></div><ul><li><a href="/biodb/bio_entities/BE0003544" target="_blank">UDP-glucuronosyltransferase 1-4</a></li>
<li><a href="/biodb/bio_entities/BE0003538" target="_blank">UDP-glucuronosyltransferase 1-9</a></li></ul></td><td><a href="/metabolites/DBMET00517">Cotinine glucuronide</a></td><td class="actions"><a class="btn btn-info btn-sm" href="/reactions/1090">Details</a></td></tr></tbody></table></td></tr><tr><th>Route of elimination</th><td>About 10% of the nicotine absorbed is excreted unchanged in the urine.</td></tr><tr><th>Half life</th><td>Cotinine has a half life of 15-20 hours, while nicotine has a half life of 1-3 hours</td></tr><tr><th>Clearance</th><td><ul>
	<li>1.2 L/min [healthy adult smoker]</li>
</ul></td></tr><tr><th>Toxicity</th><td>Symptoms of overdose include nausea, abdominal pain, vomiting, diarrhea, diaphoresis, flushing, dizziness, disturbed hearing and vision, confusion, weakness, palpitations, altered respiration and hypotension. LD<sub>50</sub>= 24 mg/kg (orally in mice).</td></tr><tr><th>Affected organisms</th><td><ul><li>Humans and other mammals</li></ul></td></tr><tr><th>Pathways</th><td class="data-table-container"><table class="table table-condensed table-striped" id="pathways"><thead><tr><th>Pathway</th><th>Category</th><th>SMPDB ID</th></tr></thead><tbody><tr><td>Nicotine Action Pathway</td><td>Drug action</td><td><a class="btn btn-default btn-xs" href="http://www.smpdb.ca/view/SMP00431?highlight%5Bcompounds%5D%5B%5D=DB00184&amp;highlight%5Bproteins%5D%5B%5D=DB00184">SMP00431</a></td></tr><tr><td>Nicotine Metabolism Pathway</td><td>Drug metabolism</td><td><a class="btn btn-default btn-xs" href="http://www.smpdb.ca/view/SMP00628?highlight%5Bcompounds%5D%5B%5D=DB00184&amp;highlight%5Bproteins%5D%5B%5D=DB00184">SMP00628</a></td></tr></tbody></table></td></tr><tr><th>SNP Mediated Effects</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>SNP Mediated Adverse Drug Reactions</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr id="admet"><th class="divider" colspan="2">ADMET</th></tr><tr><th>Predicted ADMET features</th><td class="data-table-container"><table class="table table-condensed table-striped" id="predicted-admet">
  <thead>
    <tr>
      <th>Property</th>
      <th>Value</th>
      <th>Probability</th>
    </tr>
  </thead>
  <tbody>
      <tr>
        <td>Human Intestinal Absorption</td>
        <td>
              +
        </td>
        <td>1.0</td>
      </tr>
      <tr>
        <td>Blood Brain Barrier</td>
        <td>
              +
        </td>
        <td>0.9748</td>
      </tr>
      <tr>
        <td>Caco-2 permeable</td>
        <td>
              +
        </td>
        <td>0.8867</td>
      </tr>
      <tr>
        <td>P-glycoprotein substrate</td>
        <td>
            Substrate
        </td>
        <td>0.5</td>
      </tr>
      <tr>
        <td>P-glycoprotein inhibitor I</td>
        <td>
            Non-inhibitor
        </td>
        <td>0.8998</td>
      </tr>
      <tr>
        <td>P-glycoprotein inhibitor II</td>
        <td>
            Non-inhibitor
        </td>
        <td>0.9368</td>
      </tr>
      <tr>
        <td>Renal organic cation transporter</td>
        <td>
            Inhibitor
        </td>
        <td>0.6868</td>
      </tr>
      <tr>
        <td>CYP450 2C9 substrate</td>
        <td>Non-substrate</td>
        <td>0.7998</td>
      </tr>
      <tr>
        <td>CYP450 2D6 substrate</td>
        <td>Substrate</td>
        <td>0.8918</td>
      </tr>
      <tr>
        <td>CYP450 3A4 substrate</td>
        <td>Non-substrate</td>
        <td>0.5</td>
      </tr>
      <tr>
        <td>CYP450 1A2 substrate</td>
        <td>Non-inhibitor</td>
        <td>0.6347</td>
      </tr>
      <tr>
        <td>CYP450 2C9 substrate</td>
        <td>Non-inhibitor</td>
        <td>0.8433</td>
      </tr>
      <tr>
        <td>CYP450 2D6 substrate</td>
        <td>Non-inhibitor</td>
        <td>0.8838</td>
      </tr>
      <tr>
        <td>CYP450 2C19 substrate</td>
        <td>Non-inhibitor</td>
        <td>0.8543</td>
      </tr>
      <tr>
        <td>CYP450 3A4 substrate</td>
        <td>Non-inhibitor</td>
        <td>0.8308</td>
      </tr>
      <tr>
        <td>CYP450 inhibitory promiscuity</td>
        <td>Low CYP Inhibitory Promiscuity</td>
        <td>0.7589</td>
      </tr>
      <tr>
        <td>Ames test</td>
        <td>
          Non AMES toxic 
        </td>
        <td>
            0.9133
        </td>
      </tr>
      <tr>
        <td>Carcinogenicity</td>
        <td>
          Non-carcinogens 
        </td>
        <td>
            0.9626
        </td>
      </tr>
      <tr>
        <td>Biodegradation</td>
        <td>
          Not ready biodegradable 
        </td>
        <td>
            0.9478
        </td>
      </tr>
      <tr>
        <td>Rat acute toxicity</td>
        <td>
          3.4798 
            LD50, mol/kg
        </td>
        <td>
            <span class="wishart wishart-not-available">Not applicable</span>
        </td>
      </tr>
      <tr>
        <td>hERG inhibition (predictor I)</td>
        <td>
          Weak inhibitor 
        </td>
        <td>
            0.8851
        </td>
      </tr>
      <tr>
        <td>hERG inhibition (predictor II)</td>
        <td>
          Non-inhibitor 
        </td>
        <td>
            0.7978
        </td>
      </tr>
  </tbody>
</table>
</td></tr><tr id="pharmacoeconomics"><th class="divider" colspan="2">Pharmacoeconomics</th></tr><tr><th>Manufacturers</th><td><ul><li>Novartis consumer health inc</li>
<li>Sanofi aventis us llc</li>
<li>Aveva drug delivery systems inc</li>
<li>Mcneil consumer healthcare</li>
<li>Pharmacia and upjohn co</li>
<li>Pfizer inc</li>
<li>Glaxosmithkline</li>
<li>Ivax pharmaceuticals inc sub teva pharmaceuticals usa</li>
<li>Perrigo co</li>
<li>Perrigo r and d co</li>
<li>Watson laboratories inc</li>
<li>Glaxosmithkline consumer healthcare</li></ul></td></tr><tr><th>Packagers</th><td><ul><li><a href="http://www.avevadds.com">Aveva Drug Delivery Systems Inc.</a></li>
<li><a href="http://www.cardinal.com">Cardinal Health</a></li>
<li><a href="http://www.cvs.com">CVS Pharmacy</a></li>
<li><a href="http://www.drxdispensing.com">Dispensing Solutions</a></li>
<li><a href="http://www.elan.com">Elan Pharmaceuticals Inc.</a></li>
<li><a href="http://www.gallipot.com">Gallipot</a></li>
<li><a href="http://www.gsk.com">GlaxoSmithKline Inc.</a></li>
<li><a href="http://www.ltslohmann.com">LTS Lohmann Therapy Systems Corp.</a></li>
<li><a href="http://www.mckesson.com">Mckesson Corp.</a></li>
<li>McNeil Laboratories</li>
<li><a href="http://www.novartis.com">Novartis AG</a></li>
<li><a href="http://www.perrigo.com">Perrigo Co.</a></li>
<li><a href="http://www.pfizer.com">Pfizer Inc.</a></li>
<li><a href="http://www.pharmaciaupjohn.com">Pharmacia Inc.</a></li>
<li><a href="http://www.physicianstotalcare.com">Physicians Total Care Inc.</a></li></ul></td></tr><tr><th>Dosage forms</th><td class="data-table-container"><table class="table table-condensed table-striped datatable" id="dosages"><thead><tr><th>Form</th><th>Route</th><th>Strength</th></tr></thead><tbody><tr><td>Capsule</td><td>Oral</td><td></td></tr><tr><td>Capsule, extended release</td><td>Oral</td><td></td></tr><tr><td>Disc</td><td>Transdermal</td><td></td></tr><tr><td>Drug delivery system</td><td>Respiratory (inhalation)</td><td></td></tr><tr><td>Gum</td><td>Oral</td><td></td></tr><tr><td>Liquid</td><td>Intramuscular</td><td></td></tr><tr><td>Liquid</td><td>Oral</td><td></td></tr><tr><td>Patch</td><td>Transdermal</td><td></td></tr><tr><td>Powder</td><td>Oral</td><td></td></tr><tr><td>Solution</td><td>Intramuscular</td><td></td></tr><tr><td>Solution / drops</td><td>Oral</td><td></td></tr><tr><td>Tablet</td><td>Oral</td><td></td></tr><tr><td>Tablet, extended release</td><td>Oral</td><td></td></tr></tbody></table></td></tr><tr><th>Prices</th><td class="data-table-container"><table class="table table-condensed table-striped datatable" id="prices"><thead><tr><th>Unit description</th><th>Cost</th><th>Unit</th></tr></thead><tbody><tr><td>Nicotrol 168 10 mg Inhalant Inhaler</td><td>223.5USD</td><td>inhaler</td></tr><tr><td>Nicotine 30 21 mg/24hr Patches Box</td><td>206.52USD</td><td>box</td></tr><tr><td>Nicotine 30 14 mg/24hr Patches Box</td><td>196.27USD</td><td>box</td></tr><tr><td>Nicotrol NS 10 mg/ml Solution 10ml Bottle</td><td>55.88USD</td><td>bottle</td></tr><tr><td>Nicotine polacrilex powder</td><td>11.25USD</td><td>g</td></tr><tr><td>Nicotrol ns 10 mg/ml spray</td><td>5.37USD</td><td>ml</td></tr><tr><td>Nicoderm cq 21 mg/24hr patch</td><td>4.08USD</td><td>patch</td></tr><tr><td>Nicoderm cq 14 mg/24hr patch</td><td>3.52USD</td><td>patch</td></tr><tr><td>Nicoderm cq 7 mg/24hr patch</td><td>3.52USD</td><td>patch</td></tr><tr><td>Nicotine 11 mg/24hr patch</td><td>3.14USD</td><td>patch</td></tr><tr><td>Nicotine 22 mg/24hr patch</td><td>3.14USD</td><td>patch</td></tr><tr><td>Nicotine transdermal system</td><td>1.83USD</td><td>each</td></tr><tr><td>Nicotrol cartridge inhaler</td><td>1.28USD</td><td>each</td></tr><tr><td>Commit 2 mg lozenge</td><td>0.55USD</td><td>lozenge</td></tr><tr><td>Commit 4 mg lozenge</td><td>0.55USD</td><td>lozenge</td></tr><tr><td>Nicorette 4 mg chewing gum</td><td>0.52USD</td><td>each</td></tr><tr><td>Nicorette 2 mg chewing gum</td><td>0.45USD</td><td>each</td></tr><tr><td>Thrive nicotine 2 mg gum</td><td>0.42USD</td><td>each</td></tr><tr><td>Thrive nicotine 4 mg gum</td><td>0.42USD</td><td>each</td></tr><tr><td>CVS Pharmacy nicotine 4 mg chewing gum</td><td>0.38USD</td><td>each</td></tr><tr><td>CVS Pharmacy nicotine 2 mg chewing gum</td><td>0.34USD</td><td>each</td></tr><tr><td>Nicotine 4 mg chewing gum</td><td>0.3USD</td><td>each</td></tr><tr><td>Nicotine 2 mg chewing gum</td><td>0.25USD</td><td>each</td></tr></tbody></table><div class="alert alert-warning clearfix">DrugBank does not sell nor buy drugs. Pricing information is supplied for informational purposes only.</div></td></tr><tr><th>Patents</th><td class="data-table-container"><table class="table table-condensed table-striped datatable" id="patents"><thead><tr><th>Country</th><th>Patent Number</th><th>Approved</th><th>Expires (estimated)</th></tr></thead><tbody><tr><td>United States</td><td>5656255</td><td>1994-08-12</td><td>2014-08-12</td></tr><tr><td>United States</td><td>5501236</td><td>1993-06-08</td><td>2010-06-08</td></tr><tr><td>Canada</td><td>1333051</td><td>1994-11-15</td><td>2011-11-15</td></tr></tbody></table></td></tr><tr id="properties"><th class="divider" colspan="2">Properties</th></tr><tr><th>State</th><td>liquid</td></tr><tr><th>Experimental Properties</th><td class="data-table-container"><table class="table table-condensed table-striped" id="experimental-properties"><tr><th class="head-medium">Property</th><th class="head-large">Value</th><th>Source</th></tr><tr><td>melting point</td><td>-79 &#176;C</td><td>PhysProp</td></tr><tr><td>boiling point</td><td>247 &#176;C</td><td>PhysProp</td></tr><tr><td>water solubility</td><td>1E+006 mg/L</td><td>SEIDELL,A (1941)</td></tr><tr><td>logP</td><td>1.17</td><td>HANSCH,C ET AL. (1995)</td></tr><tr><td>logS</td><td>0.79</td><td>ADME Research, USCD</td></tr><tr><td>Caco2 permeability</td><td>-4.71</td><td>ADME Research, USCD</td></tr><tr><td>pKa</td><td>3.1</td><td>TOMLIN,C (1997); pKa1</td></tr></table></td></tr><tr><th>Predicted Properties</th><td class="data-table-container"><table class="table table-condensed table-striped"><thead><tr><th class="head-medium">Property</th><th class="head-large">Value</th><th>Source</th></tr></thead><tbody><tr><td>water solubility</td><td>9.33e+01 g/l</td><td><a href="http://www.vcclab.org/lab/alogps/" target="_blank">ALOGPS</a></td></tr><tr><td>logP</td><td>0.87</td><td><a href="http://www.vcclab.org/lab/alogps/" target="_blank">ALOGPS</a></td></tr><tr><td>logP</td><td>1.16</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/property-predictors/#logp_logd">ChemAxon</a></td></tr><tr><td>logS</td><td>-0.24</td><td><a href="http://www.vcclab.org/lab/alogps/" target="_blank">ALOGPS</a></td></tr><tr><td>pKa (strongest basic)</td><td>8.86</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/property-predictors/#pka">ChemAxon</a></td></tr><tr><td>physiological charge</td><td>1</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/property-predictors/#pka">ChemAxon</a></td></tr><tr><td>hydrogen acceptor count</td><td>2</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/property-calculations/#h_bond">ChemAxon</a></td></tr><tr><td>hydrogen donor count</td><td>0</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/property-calculations/#h_bond">ChemAxon</a></td></tr><tr><td>polar surface area</td><td>16.13</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/property-calculations/#topolgical_surface">ChemAxon</a></td></tr><tr><td>rotatable bond count</td><td>1</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/property-calculations/#topology_analysis">ChemAxon</a></td></tr><tr><td>refractivity</td><td>49.66</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/property-calculations/#refractivity">ChemAxon</a></td></tr><tr><td>polarizability</td><td>18.62</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/molecular-modelling/#polarization">ChemAxon</a></td></tr><tr><td>number of rings</td><td>2</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/property-calculations/#topology_analysis">ChemAxon</a></td></tr><tr><td>bioavailability</td><td>1</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/molecular-modelling/#polarization">ChemAxon</a></td></tr><tr><td>rule of five</td><td>Yes</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/molecular-modelling/#polarization">ChemAxon</a></td></tr><tr><td>Ghose filter</td><td>Yes</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/molecular-modelling/#polarization">ChemAxon</a></td></tr><tr><td>Veber's rule</td><td>Yes</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/molecular-modelling/#polarization">ChemAxon</a></td></tr><tr><td>MDDR-like rule</td><td>No</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/molecular-modelling/#polarization">ChemAxon</a></td></tr></tbody></table></td></tr><tr id="spectra"><th class="divider" colspan="2">Spectra</th></tr><tr><th>Spectra</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr id="references"><th class="divider" colspan="2">References</th></tr><tr><th>Synthesis Reference</th><td><span class="citations"><p>Charles G. Chavdarian, Edward B. Sanders, &#8220;Process for the preparation of optically active nicotine analogs.&#8221; U.S. Patent US4321387, issued September, 1959.</p></span><a class="wishart-link-out" href="https://www.google.com/?tbm=pts#q=4321387&amp;tbm=pts" target="_blank">US4321387 <span class="glyphicon glyphicon-new-window"> </span></a></td></tr><tr><th>General Reference</th><td><span class="citations"><ol>
	<li>Nolley EP, Kelley BM: Adolescent reward system perseveration due to nicotine: studies with methylphenidate. Neurotoxicol Teratol. 2007 Jan-Feb;29(1):47-56. Epub 2006 Oct 4. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17129706">Pubmed</a></li>
	<li>de Leon J, Tracy J, McCann E, McGrory A, Diaz FJ: Schizophrenia and tobacco smoking: a replication study in another US psychiatric hospital. Schizophr Res. 2002 Jul 1;56(1-2):55-65. <a href="http://www.ncbi.nlm.nih.gov/pubmed/12084420">Pubmed</a></li>
	<li>de Leon J, Dadvand M, Canuso C, White AO, Stanilla JK, Simpson GM: Schizophrenia and smoking: an epidemiological survey in a state hospital. Am J Psychiatry. 1995 Mar;152(3):453-5. <a href="http://www.ncbi.nlm.nih.gov/pubmed/7864277">Pubmed</a></li>
	<li>Aguilar MC, Gurpegui M, Diaz FJ, de Leon J: Nicotine dependence and symptoms in schizophrenia: naturalistic study of complex interactions. Br J Psychiatry. 2005 Mar;186:215-21. <a href="http://www.ncbi.nlm.nih.gov/pubmed/15738502">Pubmed</a></li>
</ol></span></td></tr><tr><th>External Links</th><td class="data-table-container"><table class="table table-condensed table-striped" id="experimental-properties"><thead><tr><th>Resource</th><th>Link</th></tr></thead><tbody><tr><td>KEGG Drug</td><td><a class="wishart-link-out" href="http://www.genome.jp/dbget-bin/www_bget?drug:D03365" target="_blank">D03365 <span class="glyphicon glyphicon-new-window"> </span></a></td></tr><tr><td>KEGG Compound</td><td><a class="wishart-link-out" href="http://www.genome.jp/dbget-bin/www_bget?cpd:C00745" target="_blank">C00745 <span class="glyphicon glyphicon-new-window"> </span></a></td></tr><tr><td>PubChem Compound</td><td><a class="wishart-link-out" href="http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=942" target="_blank">942 <span class="glyphicon glyphicon-new-window"> </span></a></td></tr><tr><td>PubChem Substance</td><td><a class="wishart-link-out" href="http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?sid=46506924" target="_blank">46506924 <span class="glyphicon glyphicon-new-window"> </span></a></td></tr><tr><td>ChemSpider</td><td><a class="wishart-link-out" href="http://www.chemspider.com/Chemical-Structure.917.html" target="_blank">917 <span class="glyphicon glyphicon-new-window"> </span></a></td></tr><tr><td>ChEBI</td><td><a class="wishart-link-out" href="http://www.ebi.ac.uk/chebi/searchId.do?chebiId=18723" target="_blank">18723 <span class="glyphicon glyphicon-new-window"> </span></a></td></tr><tr><td>ChEMBL</td><td><a class="wishart-link-out" href="http://www.ebi.ac.uk/chembldb/index.php/compound/inspect/CHEMBL3" target="_blank">CHEMBL3 <span class="glyphicon glyphicon-new-window"> </span></a></td></tr><tr><td>Therapeutic Targets Database</td><td><a class="wishart-link-out" href="http://bidd.nus.edu.sg/group/cjttd/ZFTTDDRUG.asp?ID=DAP000175" target="_blank">DAP000175 <span class="glyphicon glyphicon-new-window"> </span></a></td></tr><tr><td>PharmGKB</td><td><a class="wishart-link-out" href="http://www.pharmgkb.org/drug/PA450626" target="_blank">PA450626 <span class="glyphicon glyphicon-new-window"> </span></a></td></tr><tr><td>HET</td><td><a class="wishart-link-out" href="http://www.ebi.ac.uk/msd-srv/chempdb/cgi-bin/cgi.pl?FUNCTION=getByCode&amp;CODE=NCT" target="_blank">NCT <span class="glyphicon glyphicon-new-window"> </span></a></td></tr><tr><td>Drug Product Database</td><td><a class="wishart-link-out" href="http://205.193.93.51/dpdonline/searchRequest.do?din=2241228" target="_blank">2241228 <span class="glyphicon glyphicon-new-window"> </span></a></td></tr><tr><td>RxList</td><td><a class="wishart-link-out" href="http://www.rxlist.com/cgi/generic2/nicotini.htm" target="_blank">http://www.rxlist.com/cgi/generic2/nicotini.htm <span class="glyphicon glyphicon-new-window"> </span></a></td></tr><tr><td>Drugs.com</td><td><a class="wishart-link-out" href="http://www.drugs.com/nicotine.html" target="_blank">http://www.drugs.com/nicotine.html <span class="glyphicon glyphicon-new-window"> </span></a></td></tr><tr><td>PDRhealth</td><td><a class="wishart-link-out" href="http://www.pdrhealth.com/drug_info/rxdrugprofiles/drugs/nic1292.shtml" target="_blank">http://www.pdrhealth.com/drug_info/rxdrugprofiles/drugs/nic1292.shtml <span class="glyphicon glyphicon-new-window"> </span></a></td></tr><tr><td>Wikipedia</td><td><a class="wishart-link-out" href="http://en.wikipedia.org/wiki/Nicotine" target="_blank">Nicotine <span class="glyphicon glyphicon-new-window"> </span></a></td></tr></tbody></table></td></tr><tr><th>ATC Codes</th><td>N07BA01<ul class="atc-drug-tree"><li><a href="/atc/N#N">N &#8212; NERVOUS SYSTEM</a></li><li><a href="/atc/N07#N07">N07 &#8212; OTHER NERVOUS SYSTEM DRUGS</a></li><li><a href="/atc/N07B#N07B">N07B &#8212; DRUGS USED IN ADDICTIVE DISORDERS</a></li><li><a href="/atc/N07BA#N07BA">N07BA &#8212; Drugs used in nicotine dependence</a></li></ul>A11HA01<ul class="atc-drug-tree"><li><a href="/atc/A#A">A &#8212; ALIMENTARY TRACT AND METABOLISM</a></li><li><a href="/atc/A11#A11">A11 &#8212; VITAMINS</a></li><li><a href="/atc/A11H#A11H">A11H &#8212; OTHER PLAIN VITAMIN PREPARATIONS</a></li><li><a href="/atc/A11HA#A11HA">A11HA &#8212; Other plain vitamin preparations</a></li></ul>C04AC01<ul class="atc-drug-tree"><li><a href="/atc/C#C">C &#8212; CARDIOVASCULAR SYSTEM</a></li><li><a href="/atc/C04#C04">C04 &#8212; PERIPHERAL VASODILATORS</a></li><li><a href="/atc/C04A#C04A">C04A &#8212; PERIPHERAL VASODILATORS</a></li><li><a href="/atc/C04AC#C04AC">C04AC &#8212; Nicotinic acid and derivatives</a></li></ul>C10AD02<ul class="atc-drug-tree"><li><a href="/atc/C#C">C &#8212; CARDIOVASCULAR SYSTEM</a></li><li><a href="/atc/C10#C10">C10 &#8212; LIPID MODIFYING AGENTS</a></li><li><a href="/atc/C10A#C10A">C10A &#8212; LIPID MODIFYING AGENTS, PLAIN</a></li><li><a href="/atc/C10AD#C10AD">C10AD &#8212; Nicotinic acid and derivatives</a></li></ul></td></tr><tr><th>AHFS Codes</th><td><ul><li>12:92.00</li>
<li>24:06.92</li>
<li>92:02.00*</li>
<li>88:08.00</li></ul></td></tr><tr><th>PDB Entries</th><td><ul><li><a class="wishart-link-out" href="http://www.rcsb.org/pdb/explore.do?structureId=1P2Y" target="_blank">1P2Y <span class="glyphicon glyphicon-new-window"> </span></a></li></ul></td></tr><tr><th>FDA label</th><td><a href="/system/fda_labels/DB00184.pdf?1265922809">show</a>(11.2 MB)</td></tr><tr><th>MSDS</th><td><a href="/system/msds/DB00184.pdf?1265922746">show</a>(77.6 KB)</td></tr><tr id="interactions"><th class="divider" colspan="2">Interactions</th></tr><tr><th>Drug Interactions</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Food Interactions</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr></tbody></table>